Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)

Authors: Jason J. Luke, Daniel J. Olson, Jacob B. Allred, Carrie A. Strand, Riyue Bao, Yuanyuan Zha, Timothy Carll, Brian W. Labadie, Bruno R. Bastos, Marcus O. Butler, David Hogg, Pamela N. Munster, Gary K. Schwartz

Published: 2019-09-26

DOI: 10.1158/1078-0432.ccr-19-1223

Source: Full article

Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)

Abstract